BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2002
View Archived Issues
Banyu researchers identify novel nociceptin ORL1 antagonists
Read More
Novel series of CRF1 antagonists prepared and tested at Eisai
Read More
Neprilysin inhibitors with utility in female arousal disorder claimed by Pfizer
Read More
Ajinomoto patent covers new inhibitors of TNF-alpha production and their use
Read More
Antidiabetic pyrazolyl glycosides in Ajinomoto development pipeline
Read More
Phase Ib/II trial of Hemospan cleared to begin in Sweden
Read More
GPI-1485 selected for evaluation in NINDS-funded Parkinson's program
Read More
Zevalin and high-dose BEAM chemotherapy in non-Hodgkin's lymphoma
Read More
Oral heparin compared to s.c. LMWH for antithrombotic efficacy after total hip replacement
Read More
AAV-mediated FIX gene therapy for hemophilia B discussed at ASH meeting
Read More
Modified dosing schedule of apolizumab allows higher doses in CLL and ALL
Read More
Nippon Shinyaku acquires rights to Trisenox in certain Asian countries
Read More
Dalbavancin enters two phase III trials for the treatment of SSTIs
Read More
Completion of phase III Riquent trial announced
Read More
Lilly's E.U. submission for ruboxistaurin delayed by phase III trial results
Read More
Keryx plans pre-IND meeting with FDA for KRX-123
Read More
Approvable letter for Advair Diskus
Read More
Fox Chase collaborates with Telik to evaluate anticancer compounds
Read More
Lantus: E.U. approval for flexible use, positive opinion for pediatric use
Read More
Calsed launched for NSCLC and SCLC
Read More
Fujisawa launches Funguard in Japan
Read More
Dainippon and Kyorin sign preliminary development agreement for AS-3201
Read More
Vertex presents novel p38 kinase inhibitors with broad range of applications
Read More
New colchicine-like antiangiogenic agents and their use in cancer and other disorders
Read More
RO-14: a new LMWH with a comparable PK/PD profile to fondaparinux in primates
Read More
HER-2 DNA AutoVac therapeutic vaccine safe and immunogenic in breast cancer patients
Read More